Family Medicine · Belen, NM
NPI
1003117698
Since 2010
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
703 South Christopher Road
Belen, NM, 87002
Phone (505) 864-7781
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
2,969 services
Medicare patients, 2024
377
Average age 72
Drug cost, 2024
$1.1M
15,851 prescriptions
Company payments, 2025
$772
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adolfo V Sanchez was code 99213 (office e&m - established), 680 times for 262 patients. In total Adolfo V Sanchez billed 2,969 services in 83 codes, and Medicare paid $103K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 680 | 262 | $57.88 | $39K |
| 99214 Office E&M - Established | Office | 465 | 224 | $86.23 | $40K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 339 | 104 | $0.09 | $29.91 |
| 96372 Injection Administration | Office | 255 | 122 | $9.65 | $2,461 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 174 | 99 | $0.72 | $126 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 78 | 63 | $0.32 | $24.75 |
| 81000 Clinical Chemistry | Office | 57 | 44 | $3.94 | $225 |
| 87804 Immunoassay | Office | 48 | 23 | $14.95 | $718 |
| 90471 Vaccine Administration | Office | 33 | 33 | $14.24 | $470 |
| 99204 Office E&M - New | Office | 32 | 32 | $118.79 | $3,801 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 29 | 29 | $122.01 | $3,538 |
| 90656 Vaccine Product | Office | 25 | 25 | $21.02 | $526 |
| G0008 Administration of influenza virus vaccine | Office | 25 | 24 | $29.57 | $739 |
| 71046 X-ray - Chest | Office | 24 | 24 | $21.64 | $519 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 22 | 14 | $0.53 | $11.63 |
By year: 2022 $155K for 3,858 services; 2023 $102K for 2,853 services; 2024 $103K for 2,969 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 57 | 44 | $3.94 | $225 |
| 87804 Immunoassay | 48 | 23 | $14.95 | $718 |
| 82962 Clinical Chemistry | 19 | 19 | $3.21 | $60.99 |
| 87880 Immunoassay | 17 | 16 | $15.25 | $259 |
Medicare prescription drug claims, 2024
In 2024, the drug Adolfo V Sanchez prescribed most often to Medicare patients was Lisinopril, with 661 prescriptions and refills. In total Adolfo V Sanchez wrote 15,851 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lisinopril Generic | 661 | 1,724 | 210 | $5,851 |
| Levothyroxine Sodium Generic | 627 | 1,596 | 192 | $6,474 |
| Atorvastatin Calcium Generic | 577 | 1,526 | 196 | $6,859 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 530 | 590 | 199 | $14K |
| Amlodipine Besylate Generic | 431 | 1,089 | 145 | $3,344 |
| Gabapentin Generic | 414 | 598 | 129 | $6,801 |
| Metformin Hcl Generic | 371 | 932 | 130 | $2,824 |
| Omeprazole Generic | 367 | 784 | 100 | $4,880 |
| Losartan Potassium Generic | 363 | 1,001 | 134 | $3,648 |
| Pantoprazole Sodium Generic | 358 | 613 | 99 | $3,829 |
| Hydrochlorothiazide Generic | 343 | 861 | 103 | $1,779 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 318 | 319 | 42 | $8,591 |
| Tamsulosin Hcl Generic | 316 | 811 | 103 | $4,733 |
| Ibuprofen Generic | 267 | 332 | 116 | $3,782 |
| Trazodone Hcl Generic | 257 | 393 | 69 | $2,140 |
Brand drugs: 1,889 claims; generic drugs: 13,859 claims; opioid claims: 584.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adolfo V Sanchez $772 ($772 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $136.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 7 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $81.54 |
| Viatris Specialty LLC | 3 | $63.39 |
| Abbvie Inc. ABBV | 3 | $62.22 |
| Lundbeck LLC | 2 | $52.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $46.99 |
| Boston Scientific Corporation BSX | 1 | $42.6 |
| Novo Nordisk Inc NVO | 2 | $37.92 |
| Aimmune Therapeutics, Inc. | 2 | $33.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.